|
Orthologous residues
|
|
E2F1 (human): S31‑p, E2F1 (mouse): S29‑p, E2F1 (rat): S29‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, immunoprecipitation, mutation of modification site
|
|
Relevant cell lines - cell types - tissues:
293T (epithelial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
ATM (human)
|
transfection of wild-type enzyme, transfection of dominant-negative enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
neocarzinostatin
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
protein stabilization
|
